Biomarin Pharmaceutical Inc (BMRN)
66.60
+0.71
(+1.08%)
USD |
NASDAQ |
Nov 01, 16:00
66.60
0.00 (0.00%)
After-Hours: 20:00
Biomarin Pharmaceutical Total Assets (Quarterly): 6.851B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.851B |
| June 30, 2024 | 7.067B |
| March 31, 2024 | 6.873B |
| December 31, 2023 | 6.842B |
| September 30, 2023 | 6.758B |
| June 30, 2023 | 6.563B |
| March 31, 2023 | 6.434B |
| December 31, 2022 | 6.375B |
| September 30, 2022 | 6.264B |
| June 30, 2022 | 6.146B |
| March 31, 2022 | 6.063B |
| December 31, 2021 | 6.005B |
| September 30, 2021 | 5.977B |
| June 30, 2021 | 5.898B |
| March 31, 2021 | 5.805B |
| December 31, 2020 | 5.848B |
| September 30, 2020 | 6.158B |
| June 30, 2020 | 5.302B |
| March 31, 2020 | 4.723B |
| December 31, 2019 | 4.690B |
| September 30, 2019 | 4.558B |
| June 30, 2019 | 4.393B |
| March 31, 2019 | 4.435B |
| December 31, 2018 | 4.427B |
| September 30, 2018 | 4.695B |
| Date | Value |
|---|---|
| June 30, 2018 | 4.625B |
| March 31, 2018 | 4.597B |
| December 31, 2017 | 4.633B |
| September 30, 2017 | 4.581B |
| June 30, 2017 | 4.020B |
| March 31, 2017 | 3.939B |
| December 31, 2016 | 4.024B |
| September 30, 2016 | 3.842B |
| June 30, 2016 | 3.087B |
| March 31, 2016 | 3.667B |
| December 31, 2015 | 3.729B |
| September 30, 2015 | 3.625B |
| June 30, 2015 | 3.649B |
| March 31, 2015 | 3.659B |
| December 31, 2014 | 2.475B |
| September 30, 2014 | 2.440B |
| June 30, 2014 | 2.346B |
| March 31, 2014 | 2.341B |
| December 31, 2013 | 2.244B |
| September 30, 2013 | 1.621B |
| June 30, 2013 | 1.602B |
| March 31, 2013 | 1.598B |
| December 31, 2012 | 1.568B |
| September 30, 2012 | 1.567B |
| June 30, 2012 | 1.533B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.690B
Minimum
Dec 2019
7.067B
Maximum
Jun 2024
6.132B
Average
6.152B
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 112.63B |
| Bristol-Myers Squibb Co | 93.67B |
| Alnylam Pharmaceuticals Inc | 4.205B |
| Bioventus Inc | 792.17M |
| Moderna Inc | 15.68B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.438B |
| Shareholders Equity (Quarterly) | 5.413B |
| Debt to Equity Ratio | 0.1098 |
| Current Ratio | 4.271 |
| Net Debt Paydown Yield | 0.73% |